Cochrane for Clinicians: Extended-Release Bupropion for Preventing Seasonal Affective Disorder in Adults

Evidence-Based Answer When started in the fall, extended-release bupropion, 300 mg once daily, is effective in preventing recurrent symptoms in high-risk adults with a history of SAD (number needed to treat [NNT] = 5), as well as those at lower risk (NNT = 8). Headaches, nausea, and insomnia may lim...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	American family physician 2017-01, Vol.95 (1), p.10
Hauptverfasser:	Magovern, Megan, Crawford-Faucher, Amy
Format:	Artikel
Sprache:	eng
Schlagworte:	Antidepressants Insomnia Mental depression Patients Scholarly publishing Seasonal affective disorder
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!